Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer.

Ghosh M, Sakhuja P, Singh S, Agarwal AK.

Saudi J Gastroenterol. 2013 Jan-Feb;19(1):34-9. doi: 10.4103/1319-3767.105922.

2.

E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.

Puhalla H, Herberger B, Soleiman A, Filipits M, Laengle F, Gruenberger T, Wrba F.

Anticancer Res. 2005 Nov-Dec;25(6B):4249-54.

3.

p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.

Agrawal V, Goel A, Krishnani N, Pandey R, Agrawal S, Kapoor VK.

J Postgrad Med. 2010 Oct-Dec;56(4):262-6. doi: 10.4103/0022-3859.70933.

4.

Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.

Zhuang PY, Zhu MJ, Wang JD, Zhou XP, Quan ZW, Shen J.

J Dig Dis. 2013 Jan;14(1):45-50. doi: 10.1111/j.1751-2980.2012.00645.x.

PMID:
23134201
5.

Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.

Shu GS, Lv F, Yang ZL, Miao XY.

Int J Clin Oncol. 2013 Aug;18(4):641-50. doi: 10.1007/s10147-012-0431-7. Epub 2012 Jun 21.

PMID:
22714709
6.

Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.

Liu DC, Yang ZL, Jiang S.

Pathol Oncol Res. 2011 Dec;17(4):859-66. doi: 10.1007/s12253-011-9394-7. Epub 2011 Apr 1.

PMID:
21455631
7.

Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.

Wang SN, Chung SC, Tsai KB, Chai CY, Chang WT, Kuo KK, Chen JS, Lee KT.

Kaohsiung J Med Sci. 2006 Feb;22(2):53-9.

8.

Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.

Xie F, Xu X, Xu A, Liu C, Liang F, Xue M, Bai L.

Hum Pathol. 2014 Mar;45(3):513-21. doi: 10.1016/j.humpath.2013.10.017. Epub 2013 Oct 30.

PMID:
24440094
9.

Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V.

Hum Pathol. 2010 Jun;41(6):867-76. doi: 10.1016/j.humpath.2009.09.019. Epub 2010 Feb 4.

PMID:
20129645
10.

Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.

Priya TP, Kapoor VK, Krishnani N, Agrawal V, Agarwal S.

Cancer Invest. 2009 Aug;27(7):764-73. doi: 10.1080/07357900802711304.

PMID:
19452299
11.

Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.

Garcia P, Leal P, Alvarez H, Brebi P, Ili C, Tapia O, Roa JC.

Arch Pathol Lab Med. 2013 Feb;137(2):245-50. doi: 10.5858/arpa.2011-0628-OA.

PMID:
23368866
13.
14.

Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.

Senol S, Yildirim A, Ceyran B, Uruc F, Zemheri E, Ozkanli S, Akalin I, Ulus I, Caskurlu T, Aydin A.

Bosn J Basic Med Sci. 2015 Aug 19;15(4):7-14. doi: 10.17305/bjbms.2015.556.

15.

The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.

da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1310-4.

PMID:
15362740
16.

Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.

Hughes NR, Bhathal PS.

J Clin Pathol. 2013 Mar;66(3):212-7. doi: 10.1136/jclinpath-2012-201146. Epub 2012 Dec 25.

PMID:
23268317
18.

Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Pećina-Šlaus N, Kafka A, Vladušić T, Tomas D, Logara M, Skoko J, Hrašćan R.

Int J Exp Pathol. 2016 Apr;97(2):159-69. doi: 10.1111/iep.12186. Epub 2016 Jun 12.

19.

DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.

Roa I, Villaseca M, Araya JC, Roa J, de Aretxabala X, Fuentealba P, Melo A.

Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):547-50.

20.

Frequent beta-catenin alteration in gallbladder carcinomas.

Kimura Y, Furuhata T, Mukaiya M, Kihara C, Kawakami M, Okita K, Yanai Y, Zenbutsu H, Satoh M, Ichimiya S, Hirata K.

J Exp Clin Cancer Res. 2003 Jun;22(2):321-8.

PMID:
12866584

Supplemental Content

Support Center